Sepsis News and Research

Latest Sepsis News and Research

Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice

A new study demonstrates lethal infection of the olfactory epithelium in a mouse model that could help understand the mechanisms of COVID-19.

12 Dec 2021

Machine-learning model could help identify treatments that pose higher risk than other options

Sepsis claims the lives of nearly 270,000 people in the U.S. each year. The unpredictable medical condition can progress rapidly, leading to a swift drop in blood pressure, tissue damage, multiple organ failure, and death.

11 Dec 2021

UEA researchers reveal how immune cells use the body’s fat stores to fight infection

New research from the University of East Anglia and Quadram Institute reveals how our immune cells use the body’s fat stores to fight infection.

9 Dec 2021

AI-based technology to identify patients at risk of serious illness as a result of blood infections

A new technology developed at Tel Aviv University will make it possible, using artificial intelligence, to identify patients who are at risk of serious illness as a result of blood infections.

8 Dec 2021

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Researchers examined autopsy tissue samples of hearts from patients who died early in the COVID-19 pandemic.

7 Dec 2021

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig for adults with PI.

7 Dec 2021

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Poolbeg Pharma, 'Poolbeg' or the 'Company', a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin and its inventor, Associate Professor Siobhán McClean, through NovaUCD, the university's knowledge transfer office.

7 Dec 2021

Using metal nanoparticles to fight SARS-CoV-2

A recent review article looks at the potential of nanotechnology in fighting severe acute respiratory syndrome 2 (SARS-CoV-2), with several possibilities of strategies in therapeutics, vaccines, and prevention.

25 Nov 2021

New AI predictive algorithm greatly improves timeliness and accuracy of sepsis predictions

Each year, sepsis affects more than 30 million people worldwide, causing an estimated six million deaths. Sepsis is the body's extreme response to an infection and is often life-threatening.

25 Nov 2021

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

A new study evaluates the efficacy of SNX-5422 as a post-exposure prophylactic treatment.

23 Nov 2021

Does SARS-CoV-2 infection contribute to adrenal gland dysfunction?

New research suggests that SARS-CoV-2 infection can directly target and cause cellular damage to the adrenal glands.

23 Nov 2021

UC researchers engineer new probiotic to target and break down cancer cell defenses

Bacteria generally have a bad reputation, as people first think of certain strains that can cause serious illnesses like pneumonia or meningitis. However, there are many helpful bacteria, known as probiotics, that assist the body in different ways.

21 Nov 2021

Commonly prescribed anticoagulants may increase UTI severity

New research by the Centenary Institute suggests that commonly prescribed anticoagulants – medicines, such as aspirin, that help prevent blood clots – may make urinary tract infections (UTIs) more severe.

17 Nov 2021

New technology could revolutionize treatment of pediatric burns

Burns are one of the most common injuries suffered by Australians and one of the top causes of death in children under four. While survival rates for burns patients have improved substantially, treating paediatric burns remains challenging, especially with the rise of multi-drug resistant bacteria.

17 Nov 2021

Two genetic risk variants in Black individuals may exacerbate sepsis and COVID-19 severity

Two genetic risk variants that are carried by nearly 40 percent of Black individuals may exacerbate the severity of both sepsis and COVID-19, a team of researchers from the University of Pennsylvania's Perelman School of Medicine have found.

16 Nov 2021

Potential therapeutic targets of hydrogen for treatment of the COVID-19

A recent article provided a review of a study led by academician Zhong Nanshan, in China, on COVID-19 treatment by inhalation of a mixed gas composed of hydrogen and oxygen.

12 Nov 2021

CDC study shows COVID-19 in newborns is rare

To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.

9 Nov 2021

Sepsis News and Research

Latest Sepsis News and Research

Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice

Machine-learning model could help identify treatments that pose higher risk than other options

UEA researchers reveal how immune cells use the body’s fat stores to fight infection

AI-based technology to identify patients at risk of serious illness as a result of blood infections

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Using metal nanoparticles to fight SARS-CoV-2

New AI predictive algorithm greatly improves timeliness and accuracy of sepsis predictions

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Does SARS-CoV-2 infection contribute to adrenal gland dysfunction?

UC researchers engineer new probiotic to target and break down cancer cell defenses

Commonly prescribed anticoagulants may increase UTI severity

New technology could revolutionize treatment of pediatric burns

Two genetic risk variants in Black individuals may exacerbate sepsis and COVID-19 severity

Potential therapeutic targets of hydrogen for treatment of the COVID-19

CDC study shows COVID-19 in newborns is rare

Study shows significant decreases in infections among people with psoriatic arthritis

Harvard researchers elucidate the underlying neuroanatomy of acupuncture

People with psychotic disorders at higher risk of hospitalization, death from infectious diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sepsis News and Research

Latest Sepsis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in